ID

22692

Descrição

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Palavras-chave

Versões (1)
  1. 09/06/2017 09/06/2017 -
Titular dos direitos

Genentech, Inc.

Transferido a

9 de junho de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

FOLLOW-UP CONTACT DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382

Inglês

FOLLOW-UP CONTACT DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382

1 Formulários  
Patient administration
Descrição

Patient administration

Subject Number
Descrição

PT

Tipo de dados

integer

Alias
UMLS CUI [1]
C2348585
Subject Initials:
Descrição

PTINIT

Tipo de dados

text

Alias
UMLS CUI [1,1]
C1997894
UMLS CUI [1,2]
C2986440
Report Date:
Descrição

VDT

Tipo de dados

date

Alias
UMLS CUI [1,1]
C1302584
FOLLOW-UP CONTACT (DAY 0)
Descrição

FOLLOW-UP CONTACT (DAY 0)

Was the subject contacted 2-4 days after study treatment?
Descrição

CONTACT [CONTAC]

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1705415
UMLS CUI [1,2]
C2709088
Date of Contact:
Descrição

CONTACT_DT [CONDT]

Tipo de dados

date

Unidades de medida
  • DD/MMM/YY
Alias
UMLS CUI [1,1]
C1705415
UMLS CUI [1,2]
C0011008
DD/MMM/YY
Has the subject been taking the prescribed self-administered post-injection antimicrobials?
Descrição

Note: If Yes was answered to any of the questions below, the subject should return as soon as possible to the clinic for a safety assessment. Record on AE or SAE CRF if appropriate.

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0338237
Decrease in Vision: Has the subject experienced a decrease in vision in the study eye since treatment?
Descrição

VISION_DECREASED [VSNDEC]

Tipo de dados

boolean

Alias
UMLS CUI [1]
C4280600
Eye Pain: Has the subject had any eye pain in the study eye since treatment?
Descrição

EYE_PAIN [EYEPN]

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0151827
Unusual Redness: Has the subject had any new or unusual redness in the study eye (other than localized redness at the injection site) since treatment?
Descrição

EYE_REDNESS [EYERED]

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0235267
New Ocular Symptoms: Has the subject experienced any other new ocular symptoms in the study eye since treatment?
Descrição

NEW_SYMPTOM [NEWSX]

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0586406
Safety Assessment Visit: Was the subject asked to return to the clinic for a safety assessment visit?
Descrição

ASSESSMENT_DONE [ASMTDN]

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0589121
UMLS CUI [1,2]
C0549076
Voltar ao início da página

Similar models

FOLLOW-UP CONTACT DAY 0 CRFs Roche FVF4170G Macular Edema NCT00473382

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Patient administration
PT
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
PTINIT
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
VDT
Item
Report Date:
date
C1302584 (UMLS CUI [1,1])
Item Group
FOLLOW-UP CONTACT (DAY 0)
CONTACT [CONTAC]
Item
Was the subject contacted 2-4 days after study treatment?
boolean
C1705415 (UMLS CUI [1,1])
C2709088 (UMLS CUI [1,2])
CONTACT_DT [CONDT]
Item
Date of Contact:
date
C1705415 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
ANTIBIOTICS_CURRENT [ABXCR]
Item
Has the subject been taking the prescribed self-administered post-injection antimicrobials?
boolean
C0338237 (UMLS CUI [1])
VISION_DECREASED [VSNDEC]
Item
Decrease in Vision: Has the subject experienced a decrease in vision in the study eye since treatment?
boolean
C4280600 (UMLS CUI [1])
EYE_PAIN [EYEPN]
Item
Eye Pain: Has the subject had any eye pain in the study eye since treatment?
boolean
C0151827 (UMLS CUI [1])
EYE_REDNESS [EYERED]
Item
Unusual Redness: Has the subject had any new or unusual redness in the study eye (other than localized redness at the injection site) since treatment?
boolean
C0235267 (UMLS CUI [1])
NEW_SYMPTOM [NEWSX]
Item
New Ocular Symptoms: Has the subject experienced any other new ocular symptoms in the study eye since treatment?
boolean
C0586406 (UMLS CUI [1])
ASSESSMENT_DONE [ASMTDN]
Item
Safety Assessment Visit: Was the subject asked to return to the clinic for a safety assessment visit?
boolean
C0589121 (UMLS CUI [1,1])
C0549076 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial